Alzheimer’s Researchers Identify Biomarkers of Response to Anavex 2-73 Treatment

Alzheimer’s Researchers Identify Biomarkers of Response to Anavex 2-73 Treatment
Researchers have identified two biomarkers that could help determine which Alzheimer’s disease patients can benefit from Anavex 2-73 treatment. The results were reported at the 2018 Alzheimer’s Association International Conference (AAIC) in Chicago. The study, “Systematic Processin
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *